D. Thomas and L. Seeff, Natural History of Hepatitis C, Clinics in Liver Disease, vol.9, issue.3, pp.383-98, 2005.
DOI : 10.1016/j.cld.2005.05.003

M. Ghany, D. Strader, D. Thomas, and L. Seeff, Diagnosis, management, and treatment of hepatitis C: An update, Hepatology, vol.11, issue.Suppl 5, pp.1335-74, 2009.
DOI : 10.1002/hep.22759

M. Fried, M. Shiffman, and K. Reddy, Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection, New England Journal of Medicine, vol.347, issue.13, pp.975-82, 2002.
DOI : 10.1056/NEJMoa020047

S. Hadziyannis, H. Sette, J. Morgan, and T. , Peginterferon-??2a and Ribavirin Combination Therapy in Chronic Hepatitis C, Annals of Internal Medicine, vol.140, issue.5, pp.346-55, 2004.
DOI : 10.7326/0003-4819-140-5-200403020-00010

M. Manns, J. Mchutchison, and S. Gordon, Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial, The Lancet, vol.358, issue.9286, pp.958-65, 2001.
DOI : 10.1016/S0140-6736(01)06102-5

H. Rna, Log 10 IU/mL) [median (IQR)

H. Baseline, Log 10 IU/mL) [median (IQR)] 5